
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $160M | -- | -- | -$0.87 | -- |
07/30/2025 | Q2 | $282.3M | -- | -- | $0.13 | -- |
04/30/2025 | Q1 | $122.5M | $131.6M | -$0.93 | -$1.03 | $0.10 |
02/19/2025 | Q4 | $139.2M | $226.6M | -$0.66 | -$0.84 | $0.18 |
11/06/2024 | Q3 | $129.9M | $133.8M | -$0.95 | -$0.98 | $0.03 |
08/01/2024 | Q2 | $149.8M | $225.3M | -$0.45 | -$0.76 | $0.31 |
05/07/2024 | Q1 | $136.4M | $119.5M | -$0.98 | -$0.83 | -$0.15 |
02/21/2024 | Q4 | $170.9M | $324.5M | -$0.06 | -$0.75 | $0.69 |
11/02/2023 | Q3 | -- | -- | -$1.03 | -$0.89 | -$0.14 |
08/09/2023 | Q2 | -- | -- | -$0.60 | -$0.71 | $0.11 |
05/03/2023 | Q1 | -- | -- | -$0.87 | -$0.76 | -$0.11 |
02/22/2023 | Q4 | -- | -- | -$0.37 | -$0.86 | $0.49 |
11/09/2022 | Q3 | -- | -- | -$0.33 | -$0.53 | $0.20 |
08/09/2022 | Q2 | -- | -- | -$0.74 | -$0.47 | -$0.27 |
05/04/2022 | Q1 | -- | -- | -$0.46 | -$0.52 | $0.06 |
02/24/2022 | Q4 | -- | -- | $1.41 | $0.31 | $1.10 |
11/03/2021 | Q3 | -- | -- | -$0.58 | -$0.32 | -$0.26 |
08/04/2021 | Q2 | -- | -- | -$0.57 | -$0.32 | -$0.25 |
05/05/2021 | Q1 | -- | -- | -$0.64 | -$0.25 | -$0.39 |
02/24/2021 | Q4 | -- | -- | -$2.44 | $0.30 | -$2.74 |
11/04/2020 | Q3 | -- | -- | -$0.22 | -$0.16 | -$0.06 |
08/05/2020 | Q2 | -- | -- | -$0.23 | -$0.28 | $0.05 |
05/06/2020 | Q1 | -- | -- | -$0.35 | -$0.12 | -$0.24 |
02/26/2020 | Q4 | -- | -- | $1.28 | $1.03 | $0.25 |
11/06/2019 | Q3 | -- | -- | $0.18 | -$0.32 | $0.50 |
08/07/2019 | Q2 | -- | -- | -$0.01 | -$0.20 | $0.19 |
05/09/2019 | Q1 | -- | -- | $0.62 | $0.78 | -$0.16 |
02/27/2019 | Q4 | -- | -- | $2.21 | -- | -- |
11/06/2018 | Q3 | -- | -- | -$0.03 | -- | -- |
08/07/2018 | Q2 | -- | -- | -$0.29 | -- | -- |
05/04/2018 | Q1 | -- | -- | -$0.01 | -- | -- |
02/27/2018 | Q4 | -- | -- | $0.02 | -- | -- |
11/07/2017 | Q3 | -- | -- | -$0.02 | -- | -- |
08/08/2017 | Q2 | -- | -- | -$0.02 | -- | -- |
05/09/2017 | Q1 | -- | -- | $0.07 | -- | -- |
02/28/2017 | Q4 | -- | -- | $0.21 | -- | -- |
11/09/2016 | Q3 | -- | -- | $0.06 | -- | -- |
08/09/2016 | Q2 | -- | -- | -$0.47 | -- | -- |
05/04/2016 | Q1 | -- | -- | -$0.52 | -- | -- |
02/25/2016 | Q4 | -- | -- | -$0.59 | -- | -- |
11/09/2015 | Q3 | -- | -- | -$0.30 | -- | -- |
Ionis Pharmaceuticals reported $131.6M worth of top line sales in its most recent quarter.
Ionis Pharmaceuticals announced earnings per share of -$0.93 which represents a beat of analyst forecast a -$1.03 per share.
Ionis Pharmaceuticals reported $130.1M that represents $0.82 per share over the last quarter.
Ionis Pharmaceuticals's earnings are forecast to decrease from -$3.04 per share to -$2.54 per share next year representing a decrease of -21.01%.
Ionis Pharmaceuticals's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.